Literature DB >> 2028867

Sarcoma in Paget disease of bone: clinical, radiologic, and pathologic features in 22 cases.

T E Moore1, A R King, M H Kathol, G Y el-Khoury, R Palmer, P R Downey.   

Abstract

The clinical, radiologic, and histologic features of 22 cases of Paget sarcoma were reviewed to determine in which patients with Paget disease these tumors are most likely to develop and what radiologic findings suggest the diagnosis. Clinical findings at presentation included pain and/or a mass (11 patients), pathologic fracture (seven), and neurologic symptoms (four). Survival time in 20 patients ranged from 5 days to 2.5 years. Two patients were lost to follow-up: one at 2 years and one at 8 years. There were 16 high-grade osteosarcomas, three chondrosarcomas, two fibrosarcomas, and one malignant fibrous histiocytoma. The most common site was the femur. Tumors also were observed in unusual sites. In one case of multifocal osteosarcoma, the tumor involved only pagetic bone. In 15 patients, Paget disease was polyostotic, clinically significant, and had been documented previously. In four patients, a sarcoma developed near the site of a fracture that had occurred between 2 months and 15 years previously. All cases showed radiologic evidence of a destructive lesion; other findings included a mass and evidence of tumor mineralization. Periosteal reaction was not observed. All but one tumor developed in a site of osteoblastic or mixed osteoblastic and lytic Paget disease. Our results suggest that sarcomas can develop in any part of any bone affected by Paget disease but are more likely to occur with advanced disease and to present with a destructive lesion without periosteal reaction.

Entities:  

Mesh:

Year:  1991        PMID: 2028867     DOI: 10.2214/ajr.156.6.2028867

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Sarcomatous change in the Pagetoid tibiae.

Authors:  Himanshu Sharma; E MacDuff; M J Jane; R Reid
Journal:  Int Orthop       Date:  2005-08-11       Impact factor: 3.075

2.  Degeneration of Paget's disease into sarcoma: clinical and therapeutic influencing factors.

Authors:  Alessandro Zati; Teresa Wanda Bilotta
Journal:  Chir Organi Mov       Date:  2008-04-12

3.  Orthopaedic . radiology . pathology conference: left hip pain in a 62-year-old man.

Authors:  Fengdong Zhao; Zhijun Hu; Shunwu Fan
Journal:  Clin Orthop Relat Res       Date:  2008-09-09       Impact factor: 4.176

Review 4.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

Review 5.  Paget's disease of bone: review with emphasis on radiologic features, Part II.

Authors:  J M Mirra; E W Brien; J Tehranzadeh
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

6.  Unusual radiological features in Paget's disease of bone.

Authors:  T E Moore; M H Kathol; G Y el-Khoury; C W Walker; P W Gendall; C G Whitten
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

Review 7.  Benign fibro-osseous lesions of the craniofacial complex. A review.

Authors:  Roy Eversole; Lan Su; Samir ElMofty
Journal:  Head Neck Pathol       Date:  2008-05-13

8.  The role of surgery and adjuvants to survival in Pagetic osteosarcoma.

Authors:  Pietro Ruggieri; Teresa Calabrò; Maurizio Montalti; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 9.  Neoplastic transformation and tumour-like lesions in Paget's disease of bone: a pictorial review.

Authors:  C López; D V Thomas; A M Davies
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

10.  Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget's disease of bone.

Authors:  Anand Merchant; Magda Smielewska; Nimit Patel; Jennifer D Akunowicz; Elizabeth A Saria; John D Delaney; Robin J Leach; Margaret Seton; Marc F Hansen
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.